NeuroAid™-II (MLC901) provides neuroprotection and enhances neuronal cell survival against kainic acid-induced excitotoxicity in vitro by activating the PI3K/AKT pathway
Abstract In the twenty-first century, in vitro models of excitotoxic injury, leveraging advanced cellular and molecular technologies, offer a promising alternative to animal studies. These models provide a more precise understanding of injury mechanisms. Method: This study utilizes kainic acid (KA),...
Main Authors: | , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
SpringerOpen
2025-03-01
|
丛编: | Future Journal of Pharmaceutical Sciences |
主题: | |
在线阅读: | https://doi.org/10.1186/s43094-025-00782-x |